Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)
NCT01027676
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER_GOV
Sponsor class
Conditions
Non-Small-Cell Lung Carcinoma
Interventions
DRUG:
Study treatment
Sponsor
National Cancer Center, Korea
Collaborators
[object Object]